PT-141 Bremelanotide

PT-141, also known as Bremelanotide, is a synthetic peptide that acts on melanocortin receptors in the central nervous system. Its mechanism of action has been studied in published clinical research in the context of sexual health. PT-141 is prescribed by independent licensed healthcare providers for sexual health indications when deemed clinically appropriate following thorough examinations.

Formulation:

Injections: 10 mg/ml - 2 mL Vial

Potential Uses - as determined by your independent licensed healthcare provider:

– May be prescribed for erectile dysfunction when deemed clinically appropriate
– May be prescribed for female sexual dysfunction indications when deemed clinically appropriate
– May influence libido as part of a provider-directed treatment plan

These are potential clinical uses for which PT-141 has been studied. Whether PT-141 is appropriate for you is a determination made solely by your independent licensed healthcare provider following a thorough clinical evaluation. Individual results vary significantly and are not guaranteed.

Product Purchase Includes:

– Medication
– Medical provider consultation
– Syringes
– Alcohol Pads
– Program guide
– Administration video

Administration and Frequency:

– Available in Subcutaneous (SQ) Injection
– Once before activity

Contraindications

Compounded PT-141 may not be appropriate for an individual who:
– Has known cardiovascular disease, including uncontrolled hypertension, a history of heart attack, stroke, or significant cardiac arrhythmia; PT-141 is associated with transient increases in blood pressure and decreases in heart rate. Discuss your cardiovascular history with your provider before starting.
– Have a personal or family history of melanoma or other melanocytic tumors; PT-141-stimulated melanocyte activity is not fully characterized.
– Are currently taking medications that affect blood pressure, particularly those for hypertension or cardiovascular conditions. Discuss all medications with your provider
– Are pregnant or breastfeeding; discuss with your independent licensed healthcare provider before use.
– Have known hypersensitivity to bremelanotide or any component of the formulation

Warnings and Precautions

– Transient blood pressure and heart rate changes: PT-141 has been associated with transient increases in blood pressure and decreases in heart rate following administration. These effects are typically short-lived but may be significant in patients with underlying cardiovascular conditions. Blood pressure should be monitored, and patients should not use PT-141 if they have uncontrolled hypertension or significant cardiovascular disease.
– Hyperpigmentation: Melanocortin receptor stimulation may cause focal hyperpigmentation of the face, gums, or breasts, particularly with repeated use. This effect may not be fully reversible. Discuss this risk with your provider.
– Nausea: Nausea is the most commonly reported side effect and may be significant. It is typically transient but can be dose-dependent.
– Drug interactions: PT-141 may interact with medications that affect cardiovascular function or blood pressure. Disclose all current medications to your prescribing provider.
– Use with other sexual dysfunction treatments: The safety of combining PT-141 with phosphodiesterase-5 inhibitors (such as those used for ED) has not been fully established. Discuss any combination use with your provider.

Patients should inform their healthcare provider of all medical conditions, medications, and supplements before receiving this compounded formulation.

Potential Side Effects

Reported side effects may include:
– Nausea - the most commonly reported side effect; may be significant and dose-dependent
– Flushing (warmth, redness, tingling of the skin)
– Headache
– Transient increase in blood pressure
– Transient decrease in heart rate
– Focal hyperpigmentation (darkening of skin on the face, gums, or breasts) with repeated use
– Injection site pain, redness, or irritation
– Fatigue
– Dizziness

Seek immediate medical attention if you experience signs of a severe allergic reaction, including hives, swelling of the face or throat, or difficulty breathing. Contact your prescribing provider promptly if you experience chest pain, significant changes in blood pressure, or unexpected concerning symptoms.